AR215616A1 - Derivado de uretano ciclico de un omega-amino-2-hidroxialdehido,util como un material de partida para la produccion de derivados de aminoglicosidos antibacterianos,y procedimiento para la preparacion de estos ultimos - Google Patents

Derivado de uretano ciclico de un omega-amino-2-hidroxialdehido,util como un material de partida para la produccion de derivados de aminoglicosidos antibacterianos,y procedimiento para la preparacion de estos ultimos

Info

Publication number
AR215616A1
AR215616A1 AR266681A AR26668177A AR215616A1 AR 215616 A1 AR215616 A1 AR 215616A1 AR 266681 A AR266681 A AR 266681A AR 26668177 A AR26668177 A AR 26668177A AR 215616 A1 AR215616 A1 AR 215616A1
Authority
AR
Argentina
Prior art keywords
hydroxialdehyde
omega
amino
last
procedure
Prior art date
Application number
AR266681A
Other languages
English (en)
Spanish (es)
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of AR215616A1 publication Critical patent/AR215616A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20Carbocyclic rings
    • C07H15/22Cyclohexane rings, substituted by nitrogen atoms
    • C07H15/222Cyclohexane rings substituted by at least two nitrogen atoms
    • C07H15/226Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings
    • C07H15/234Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings attached to non-adjacent ring carbon atoms of the cyclohexane rings, e.g. kanamycins, tobramycin, nebramycin, gentamicin A2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18Oxygen atoms
    • C07D263/20Oxygen atoms attached in position 2
    • C07D263/24Oxygen atoms attached in position 2 with hydrocarbon radicals, substituted by oxygen atoms, attached to other ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/041,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/061,3-Oxazines; Hydrogenated 1,3-oxazines not condensed with other rings
    • C07D265/081,3-Oxazines; Hydrogenated 1,3-oxazines not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D265/101,3-Oxazines; Hydrogenated 1,3-oxazines not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with oxygen atoms directly attached to ring carbon atoms
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
AR266681A 1976-02-25 1977-02-25 Derivado de uretano ciclico de un omega-amino-2-hidroxialdehido,util como un material de partida para la produccion de derivados de aminoglicosidos antibacterianos,y procedimiento para la preparacion de estos ultimos AR215616A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB7529/76A GB1529243A (en) 1976-02-25 1976-02-25 Process for the preparation of aminoglycoside derivatives and cyclic urethane intermediates for use therein

Publications (1)

Publication Number Publication Date
AR215616A1 true AR215616A1 (es) 1979-10-31

Family

ID=9834870

Family Applications (1)

Application Number Title Priority Date Filing Date
AR266681A AR215616A1 (es) 1976-02-25 1977-02-25 Derivado de uretano ciclico de un omega-amino-2-hidroxialdehido,util como un material de partida para la produccion de derivados de aminoglicosidos antibacterianos,y procedimiento para la preparacion de estos ultimos

Country Status (26)

Country Link
US (1) US4107435A (US20080293856A1-20081127-C00150.png)
JP (1) JPS52111545A (US20080293856A1-20081127-C00150.png)
AR (1) AR215616A1 (US20080293856A1-20081127-C00150.png)
AT (1) AT348123B (US20080293856A1-20081127-C00150.png)
BE (1) BE851777A (US20080293856A1-20081127-C00150.png)
CA (1) CA1071624A (US20080293856A1-20081127-C00150.png)
CH (1) CH618706A5 (US20080293856A1-20081127-C00150.png)
CS (2) CS195714B2 (US20080293856A1-20081127-C00150.png)
DD (2) DD135200A5 (US20080293856A1-20081127-C00150.png)
DE (1) DE2708008C3 (US20080293856A1-20081127-C00150.png)
DK (1) DK82177A (US20080293856A1-20081127-C00150.png)
EG (1) EG12650A (US20080293856A1-20081127-C00150.png)
ES (1) ES456304A1 (US20080293856A1-20081127-C00150.png)
FI (1) FI770568A (US20080293856A1-20081127-C00150.png)
FR (2) FR2351109A1 (US20080293856A1-20081127-C00150.png)
GB (1) GB1529243A (US20080293856A1-20081127-C00150.png)
GR (1) GR66424B (US20080293856A1-20081127-C00150.png)
HU (1) HU179565B (US20080293856A1-20081127-C00150.png)
IE (1) IE44885B1 (US20080293856A1-20081127-C00150.png)
LU (1) LU76829A1 (US20080293856A1-20081127-C00150.png)
NL (2) NL166265C (US20080293856A1-20081127-C00150.png)
PL (2) PL102193B1 (US20080293856A1-20081127-C00150.png)
PT (1) PT66229B (US20080293856A1-20081127-C00150.png)
RO (1) RO76081A (US20080293856A1-20081127-C00150.png)
SE (1) SE7702066L (US20080293856A1-20081127-C00150.png)
SU (1) SU659092A3 (US20080293856A1-20081127-C00150.png)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5461151A (en) * 1977-10-25 1979-05-17 Shionogi & Co Ltd Novel aminoglycoside derivative
US4327087A (en) * 1978-01-16 1982-04-27 Schering Corporation Stabilized Netilmicin formulations
US4223022A (en) * 1978-01-16 1980-09-16 Schering Corporation Stabilized aminoglycoside antibiotic formulations
JPS5538345A (en) * 1978-09-11 1980-03-17 Shionogi & Co Ltd Novel aminoglycoside derivative
US4226980A (en) * 1978-12-07 1980-10-07 Abbott Laboratories Novel derivatives of fortimicin B and process for preparing same
DE2924659A1 (de) * 1979-06-19 1981-01-22 Bayer Ag Pseudotrisaccharide, ihre herstellung und verwendung als arzneimittel
DE3000841A1 (de) * 1980-01-11 1981-07-16 Bayer Ag, 5090 Leverkusen Isolierung und reinigung von aminoglycosid-antibiotiaka
DE3101376A1 (de) * 1981-01-17 1982-09-02 Bayer Ag, 5090 Leverkusen Sisomicin-derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
US4427663A (en) 1982-03-16 1984-01-24 Merck & Co., Inc. 4"-Keto-and 4"-amino-4"-deoxy avermectin compounds and substituted amino derivatives thereof
US7794713B2 (en) 2004-04-07 2010-09-14 Lpath, Inc. Compositions and methods for the treatment and prevention of hyperproliferative diseases
US7862812B2 (en) 2006-05-31 2011-01-04 Lpath, Inc. Methods for decreasing immune response and treating immune conditions
US8314071B2 (en) * 2007-12-21 2012-11-20 Massachusetts Institute Of Technology Bioactive molecules from co-cultivation of microbes
WO2018005964A1 (en) * 2016-07-01 2018-01-04 Wake Forest University Health Sciences Modified carbohydrates, compositions comprising the same, and methods of making and using the same
US10766970B2 (en) 2016-07-01 2020-09-08 Wake Forest University Health Sciences Modified carbohydrates, compositions comprising the same, and methods of making and using the same

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2399118A (en) * 1942-02-13 1946-04-23 Mallinckrodt Chemical Works 2-oxazolidone compounds and method for preparing the same
SE324857B (US20080293856A1-20081127-C00150.png) * 1962-04-03 1970-06-15 Rit Rech Ind Therapeut

Also Published As

Publication number Publication date
IE44885L (en) 1977-08-25
DE2708008A1 (de) 1977-09-01
SE7702066L (sv) 1977-08-26
CH618706A5 (US20080293856A1-20081127-C00150.png) 1980-08-15
NL166265C (nl) 1981-07-15
BE851777A (fr) 1977-08-24
FR2351109B1 (US20080293856A1-20081127-C00150.png) 1981-07-24
JPS52111545A (en) 1977-09-19
RO76081A (ro) 1981-08-17
CA1071624A (en) 1980-02-12
PT66229B (en) 1978-07-17
FR2351127A1 (fr) 1977-12-09
DE2708008B2 (de) 1981-07-02
CS195714B2 (en) 1980-02-29
PL102193B1 (pl) 1979-03-31
HU179565B (en) 1982-11-29
GR66424B (US20080293856A1-20081127-C00150.png) 1981-03-20
PT66229A (en) 1977-03-01
CS195715B2 (en) 1980-02-29
AT348123B (de) 1979-01-25
PL103737B1 (pl) 1979-07-31
IE44885B1 (en) 1982-05-05
US4107435A (en) 1978-08-15
DE2708008C3 (de) 1982-04-22
DD135200A5 (de) 1979-04-18
ES456304A1 (es) 1978-01-16
NL7901693A (nl) 1979-07-31
SU659092A3 (en) 1979-04-25
EG12650A (en) 1979-06-30
FI770568A (US20080293856A1-20081127-C00150.png) 1977-08-26
FR2351109A1 (fr) 1977-12-09
NL7701980A (nl) 1977-08-29
GB1529243A (en) 1978-10-18
DK82177A (da) 1977-08-26
LU76829A1 (US20080293856A1-20081127-C00150.png) 1978-10-18
DD130150A5 (de) 1978-03-08
ATA116777A (de) 1978-06-15
NL166265B (nl) 1981-02-16
FR2351127B1 (US20080293856A1-20081127-C00150.png) 1981-06-12

Similar Documents

Publication Publication Date Title
ES490645A0 (es) Un procedimiento para la produccion de un derivado 4-amino- 3-carboxi o ciano-1,2-dihidro-2-oxo-1,8-naftiridina
MX150529A (es) Procedimiento mejorado para la produccion de urea
AR215616A1 (es) Derivado de uretano ciclico de un omega-amino-2-hidroxialdehido,util como un material de partida para la produccion de derivados de aminoglicosidos antibacterianos,y procedimiento para la preparacion de estos ultimos
MX148042A (es) Procedimiento mejorado para la produccion de urea-amoniaco
AR225666A1 (es) Procedimiento para la produccion de derivados para la produccion de derivados de 1-alquil-1-alquenil,alcoxi o alquil-3-5-alquil,fenil o halo-3-isoxazolilourea
ES496164A0 (es) Un procedimiento para la produccion de nuevos derivados heterociclicos,.
AR217455A1 (es) Maquina para la produccion de filtros de cigarrillo
MX3635E (es) Procedimiento para la produccion de compuestos de 3-aciloximetilcefem
ES489184A0 (es) Procedimiento para la produccion de derivados de feobromina.
AR208001A1 (es) Procedimiento mejorado para la produccion de uroquinasa
MX4373E (es) Metodo mejorado para la produccion de dextrosa pulverizada
AR217659A1 (es) Procedimiento para la produccion de nuevos derivados sustituidos de o-fenilendiamina
BR7307920D0 (pt) Processo para obtencao de uma modificacao beta, estavel
MX3512E (es) Procedimiento para producir carbamatos de n-aminosulfenilo
AR206658A1 (es) Procedimiento para la produccion de nuevos diariloxi-imidazolilacetales
AR214759A1 (es) Procedimiento para la produccion de heparina
AR219281A1 (es) Metodo para la preparacion de derivados de 2-acilamino oxabol con actividad farmacologica
AR220521A1 (es) Procedimiento para la produccion de un dibenzo(b,d)-pirano
AR209993A1 (es) Un procedimiento para la produccion de la mezcia antibiotica a-30912
AR228123A1 (es) Procedimiento para la produccion de halogenoacilamidas
BR7600240A (pt) Processo para a preparacao de tiofosfatos de o,o-dialcoil-s-benzila
AR212717A1 (es) Procedimiento para la produccion del antibiotico bl580 delta
AR213076A1 (es) Procedimiento para la produccion de derivados de la glicilglicilanilida sustituida
BR7304708D0 (pt) Processo para a preparacao de esteramidas de acido s-(amido carbonil) - metil-monotiofosforico, bem como composicoes inseticidas e acaricidas a base destes
AR211114A1 (es) Procedimiento para la produccion de nuevas bencilaminas.